Home » Topics » BioWorld Science

BioWorld Science
RSS

JNJ-78278343 enters phase I trial for advanced prostate cancer

July 30, 2021

Eli Lilly presents SAD and MAD data for LY-3372689 in healthy volunteers

July 30, 2021

S2X259, novel human MAb with potential to overcome the emergence of SARS-CoV-2 variants

July 30, 2021

Enrollment opens in phase IIa study of MT-3921 for acute traumatic cervical spinal cord injury

July 30, 2021

FDA clears IND application for DCR-AUD

July 30, 2021

In vivo gene editing alleviates amyloid pathologies

July 30, 2021

Positive phase II data for LB-1148 in patients undergoing gastrointestinal surgery

July 30, 2021

KV-998083 effective in models of thrombosis and vascular leakage

July 30, 2021

AUG-3387 binds and neutralizes the SARS-CoV-2 Delta variant in vitro

July 30, 2021

Initial data reported from phase Ib study of ATRC-101

July 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...